News tagged with omeprazole
Omeprazole
Omeprazole (INN) ( /oʊˈmɛprəzoʊl/) is a proton pump inhibitor used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD), laryngopharyngeal reflux (LPR) and Zollinger–Ellison syndrome. Omeprazole is one of the most widely prescribed drugs internationally and is available over the counter in some countries.
For more information about Omeprazole, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Study shows zinc salts offer rapid relief from gastric reflux
(PhysOrg.com) -- In a study that could revolutionize how millions of people are treated for painful gastric acid-related diseases, a team led by Yale School of Medicine researchers has shown that zinc salts offer rapid, prolonged ...
Aug 24, 2010 |
4.3 / 5 (6) |
0
|
New combination therapy looks promising against ulcer bacteria
Results of a new study reveal that a seven-day course of LOAD therapy is superior to LAC at eliminating the H. pylori bacterium in patients with gastritis and peptic ulcers.
Oct 26, 2009 |
1 / 5 (1) |
0
Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine
Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines ...
Sep 24, 2009 |
not rated yet |
0
Study shows benefits of anti-clotting medications reduced by common heartburn drugs
The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for ...
Medicine & Health / Medications
May 06, 2009 |
not rated yet |
0
Search results for omeprazole
New model predicts environmental effect of pharmaceutical products
Most synthetic chemical products used in consumer goods end up unchanged in the environment. Given the risks this could pose for the environment and human health, researchers from the Autonomous University ...
Jul 28, 2011 |
not rated yet |
0
Proton-pump inhibitors and birth defects -- some reassurances, but more needed warns epidemiologist
Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epi ...
Nov 24, 2010 |
not rated yet |
0
Overhaul 'made-to-order' drugs, which cost NHS millions, urges DTB
The provision of made-to-order drugs ("specials") in primary care is expensive, often unnecessary, and associated with legal pitfalls, says the Drug and Therapeutics Bulletin (DTB).
Medicine & Health / Medications
Oct 06, 2010 |
not rated yet |
0
New evidence on co-prescribing for heart and stroke patients
New research by the University of East Anglia (UEA) shows no risk in combining two commonly-prescribed treatments for patients at risk of heart attacks and strokes.
Medicine & Health / Medications
Apr 08, 2010 |
not rated yet |
0
Case studies: Dietary supplements with steroids pose health danger
Three cases of patients suffering from the adverse affects of steroid-enriched dietary supplements have been reported by researchers at Henry Ford Hospital.
Aug 04, 2009 |
not rated yet |
0
Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease
In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective proper ...
Medicine & Health / Neuroscience
Apr 22, 2009 |
not rated yet |
0
Proton pump inhibitors increase risk of heart attacks for patients on common cardiac drug
Patients taking the common cardiac drug clopidogrel following a heart attack are at a significantly higher risk of a recurrence if they are also taking widely used acid-lowering medications called proton pump inhibitors, ...
Jan 28, 2009 |
not rated yet |
0
Canadian study OKs Losec and Nexium
Health Canada has completed a review of safety information for Losec (omeprazole) and Nexium (esomeprazole) and found no increased cardiovascular risks.
Medicine & Health / Medications
Feb 27, 2008 |
4 / 5 (1) |
0
List of search results for omeprazole
